A recent NIH-supported study found a significant association between a genetic variant in people of African ancestry and an increased risk of developing Parkinson's disease. The variant, in the GBA1 gene, is associated with a higher risk of 3.5 times for those carrying two copies.
The NIH has launched phase 2 clinical trials to evaluate at least four potential treatments for long COVID, including drugs, biologics, and therapies. These trials aim to identify effective treatments swiftly by evaluating multiple treatments simultaneously.
A study led by Professor Mary Naylor demonstrates a model of care that has important implications for the nation's healthcare system. Advanced practice nurses coordinated care provided by various healthcare team members to reduce hospital readmissions and improve patient outcomes.
Researchers found that pulmonary hypertension, a complication of sickle cell disease, causes significant mortality in adults. A study of 195 patients revealed that up to 40% of those with the condition developed high blood pressure in their lungs, leading to premature death.
The National Center for Complementary and Alternative Medicine (NCCAM) has announced a new research fellowship program to support outstanding researchers in CAM. The fellowship aims to prepare the next generation of leaders in CAM research, with a focus on clinical, translational, and laboratory-based studies.
NCCAM is offering grants to establish new research centers focused on complementary and alternative medicine. The centers will support program project grants, developmental cooperative agreements, and planning grants for international institutions.
The NIH has granted $3.5 million in funding to four institutions to enhance their human embryonic stem cell (hESC) research infrastructure. The funds will support the expansion, testing, quality assurance, and distribution of existing cell lines, enabling basic scientists to access these cells for research.
The NIH Office of Dietary Supplements is expanding its research support for dietary supplements, with new grants focused on the role of antioxidants in preventing cataract development and intestinal supplementation of amino acids in infants. The ODS will also continue to fund five existing studies in various areas of health and disease.
Scientists at NIH have identified a gene alteration associated with NPC, leading to improved diagnosis and understanding of the disease. The finding also offers insights into cholesterol metabolism and may contribute to treatments for atherosclerosis.